Q2 2026 Holdings
Filed 2026-08-14 | 43 holdings | $322.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $50.9M | 7,350,000 | 15.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $33.6M | 7,200,000 | 10.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $33.5M | 865,000 | 10.4% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $19.5M | 500,000 | 6.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $18.1M | 970,000 | 5.6% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $17.9M | 3,700,000 | 5.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $11.8M | 290,000 | 3.7% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $10.0M | 335,000 | 3.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $9.2M | 2,435,000 | 2.9% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $8.8M | 764,876 | 2.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $8.1M | 160,000 | 2.5% |
| Arrivent Biopharma Inc(AVBP)Call | COM | 04272N102 | $6.4M | 183,000 | 2.0% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $6.3M | 3,000,000 | 1.9% |
| Bioage Labs Inc(BIOA)Call | COM | 09077V100 | $6.1M | 250,000 | 1.9% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $6.1M | 3,000,000 | 1.9% |
| Adagene Inc(ADAG) | ADS | 005329107 | $5.3M | 1,250,000 | 1.6% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $4.8M | 225,000 | 1.5% |
| Rezolute Inc(RZLT)Call | COM NEW | 76200L309 | $4.7M | 900,000 | 1.5% |
| Inflarx NV(IFRX) | COM | N44821101 | $4.5M | 2,000,000 | 1.4% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $4.4M | 160,000 | 1.4% |
| Compass Pathways PLC(CMPS)Call | SPONSORED ADS | 20451W101 | $4.3M | 305,000 | 1.3% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $4.3M | 324,977 | 1.3% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $4.3M | 260,000 | 1.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.2M | 300,000 | 1.3% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $4.0M | 85,000 | 1.2% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $3.9M | 52,000 | 1.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $3.8M | 155,000 | 1.2% |
| Scynexis Inc(SCYX) | COM | 811292309 | $3.1M | 756,884 | 1.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $2.8M | 1,511,496 | 0.9% |
| Disc Medicine Inc(IRON)Call | COM | 254604101 | $2.2M | 30,000 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.1M | 403,410 | 0.7% |
| Lipocine Inc New(LPCN) | COM NEW | 53630X203 | $2.1M | 810,000 | 0.6% |
| Zentalis Pharmaceuticals Inc(ZNTL)Call | COM | 98943L107 | $2.1M | 426,000 | 0.6% |
| C4 Therapeutics Inc(CCCC)Call | COM STK | 12529R107 | $1.9M | 400,000 | 0.6% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $1.8M | 55,000 | 0.6% |
| CUE Biopharma Inc(CUE) | COM | 22978P205 | $1.6M | 50,000 | 0.5% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $1.3M | 1,244,864 | 0.4% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A305 | $734.4K | 40,375 | 0.2% |
| Nuvectis Pharma Inc(NVCT)Call | COM | 67080T108 | $711.7K | 38,700 | 0.2% |
| Pasithea Therapeutics Corp(KTTA) | COM NEW | 70261F202 | $515.4K | 1,000,000 | 0.2% |
| Inmed Pharmaceuticals Inc(INM) | COM NEW | 457637700 | $503.8K | 325,000 | 0.2% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $170.0K | 100,000 | 0.1% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $103.1K | 64,464 | 0.0% |